Janus Henderson Group
CRMD icon

Janus Henderson Group’s CorMedix CRMD Stock Holding History

Janus Henderson Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183K Hold
26,900
– – ﹤0.01% 2342
2025
Q4 		$313K Sell
26,900
-171,479
-86% -$1.9M ﹤0.01% 2192
2025
Q3 		$2.31M Buy
198,379
+171,479
+637% +$2.07M ﹤0.01% 1269
2025
Q2 		$331K Hold
26,900
– – ﹤0.01% 2134
2025
Q1 		$181K Buy
+26,900
New +$278K ﹤0.01% 2384

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Janus Henderson Group's CRMD Position: Q1 2026 in Review

Janus Henderson Group held its CorMedix (CRMD) position steady in Q1 2026 at 26,900 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Janus Henderson Group first reported a position in CRMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.31M in Q3 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Janus Henderson Group held 26,900 shares of CorMedix worth $183K as of Q1 2026.
  • Janus Henderson Group left its CorMedix share count unchanged in Q1 2026.
  • CorMedix made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2342 holding.
  • Janus Henderson Group first reported a position in CorMedix in Q1 2025 and has held it in 5 quarters since.
  • Janus Henderson Group's CorMedix position peaked at $2.31M in Q3 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.